Heart-lung Machine Market Size & Growth Forecast 2027–2036, By Segments (Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Heart-lung Machine Market size was assessed at USD 388.19 Million in 2026 and is poised to grow at 5.08% CAGR between 2027 and 2036, reaching USD 637.15 Million by 2036. The industry revenue for 2027 is calculated at USD 404.61 Million.
Get more details on this report
Request Free Sample ReportHeart-lung Machine Market Intelligence Snapshot
Regional Market Dynamics
- North America led in 2026, supported by advanced cardiovascular infrastructure, specialized hospitals, complex surgical procedures, clinical expertise, and investment in advanced operating facilities.
- Asia Pacific is the fastest-growing region, supported by expanding cardiac-care infrastructure, specialized surgery access, medical training, healthcare expenditure, and advanced operating-room investment.
Segment Momentum
- Cardiac surgeries held a 42.82% share in 2026 because heart-lung machines are essential for maintaining circulation during complex open-heart procedures and supporting surgical precision and patient safety.
- Ambulatory surgical centers are growing fastest as healthcare providers pursue efficient workflows, cost-effective treatment, minimally invasive techniques, and expanded outpatient capabilities for selected cardiovascular procedures.
Market Expansion Drivers
- Rising cardiovascular disease prevalence increasing demand for advanced cardiac surgery support systems
- Growing number of transplant and bypass surgeries driving adoption of perfusion technologies
- Technological improvements in extracorporeal circulation systems enhancing surgical safety and outcomes
Leading Market Participants
- Top players in the heart-lung machine market include Getinge AB (Sweden), LivaNova PLC (United Kingdom), Medtronic plc (Ireland), Terumo Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Koninklijke Philips N.V. (Netherlands), Edwards Lifesciences Corporation (United States), Nipro Corporation (Japan), Braile Biomedica (Brazil), Eurosets S.r.l. (Italy)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 388.19 Million
- 2027 Estimated Market Size: USD 404.61 Million
- Projected Market Size: USD 637.15 Million by 2036
- Growth Forecast: 5.08% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Cardiac Surgeries (Application) | Hospitals and Clinics (End Use)
- Emerging Opportunity Segment: Acute Respiratory Failure Treatment (Application) | Ambulatory Surgical Centers (End Use)
Market Growth Drivers and Industry Trends
Rising cardiovascular disease prevalence increasing demand for advanced cardiac surgery support systems
The increasing burden of cardiovascular conditions is driving greater utilization of advanced medical technologies that support complex cardiac procedures. The heart-lung machine market growth is driven by rising cardiovascular disease prevalence, which is increasing the need for extracorporeal circulation systems during surgeries requiring temporary heart and lung function support. Hospitals and surgical centers are adopting advanced cardiac support equipment to improve procedural capabilities and manage the growing demand for cardiovascular interventions.
Growing number of transplant and bypass surgeries driving adoption of perfusion technologies
Increasing volumes of cardiac bypass procedures and organ transplant surgeries are creating sustained demand for reliable perfusion systems. The heart-lung machine market will expand as healthcare providers adopt advanced perfusion technologies to maintain blood circulation and oxygenation during procedures requiring cardiopulmonary support. These systems remain essential in complex surgical environments where precise control of physiological conditions is required.
Technological improvements in extracorporeal circulation systems enhancing surgical safety and outcomes
Continuous advancements in extracorporeal circulation technologies are improving system performance, monitoring capabilities, and patient safety during cardiac procedures. The heart-lung machine market demand will increase as improved designs enable more accurate control of blood flow, oxygen delivery, and operational parameters during surgery. Enhanced automation and monitoring features are helping medical teams reduce procedural risks and achieve more consistent surgical outcomes.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular disease prevalence increasing demand for advanced cardiac surgery support systems | 2% | High | North America, Europe | High | Near Term |
| Growing number of transplant and bypass surgeries driving adoption of perfusion technologies | 1.8% | High | North America, Asia Pacific | High | Near Term |
| Technological improvements in extracorporeal circulation systems enhancing surgical safety and outcomes | 1.5% | High | Europe, North America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the heart-lung machine market in 2026, benefiting from advanced cardiovascular care infrastructure, a high concentration of specialized hospitals, and widespread access to complex surgical procedures. The region's established cardiac surgery ecosystem supports demand for heart-lung machines in procedures requiring cardiopulmonary support, particularly within specialized surgical centers. Continuous improvements in extracorporeal circulation technologies and the emphasis on surgical safety and patient outcomes are encouraging healthcare providers to adopt sophisticated equipment. Strong clinical expertise, investment in hospital infrastructure, and the availability of advanced operating facilities further reinforce North America's leading position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is projected to be the fastest-growing regional market, fueled by expanding cardiac care infrastructure, increasing access to specialized surgery, and a growing burden of cardiovascular conditions. Healthcare systems across developing economies are investing in advanced operating rooms and critical-care capabilities to address rising demand for complex cardiovascular interventions. Improvements in medical training and the expansion of specialized hospitals are also enabling wider use of cardiopulmonary bypass technologies. Moreover, increasing healthcare expenditure and efforts to improve access to advanced surgical treatment are supporting the adoption of heart-lung machines throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Advanced Cardiac ProceduresThe U.S. heart-lung machine market is supported by continued investment in complex cardiac surgery and perfusion technologies. Healthcare providers in the U.S. prioritize systems that improve procedural reliability, monitoring capabilities, and integration with modern operating room environments.
Germany 🇩🇪
Precision Perfusion SystemsGermany emphasizes heart-lung machines engineered for dependable performance, clinical precision, and advanced perfusion management. Hospitals in Germany continue adopting technologies that enhance surgical efficiency while supporting high standards of cardiovascular care.
Japan 🇯🇵
Surgical Technology RefinementJapan focuses on heart-lung machines that combine compact system design with precise perfusion control for complex cardiac procedures. Manufacturers in Japan continue advancing equipment reliability and user-centered functionality to support specialized surgical teams.
South Korea 🇰🇷
Cardiac Care ModernizationSouth Korea continues expanding advanced cardiac surgery capabilities through investment in modern heart-lung machine technologies. Healthcare providers in South Korea prioritize equipment that supports efficient perfusion management and improved integration with digital operating room systems.
France 🇫🇷
Specialized Surgical SupportFrance maintains demand for heart-lung machines that meet the requirements of specialized cardiovascular surgery programs. Medical institutions in France emphasize dependable perfusion technologies, clinical safety, and equipment upgrades that support complex surgical procedures.
Italy 🇮🇹
Hospital Equipment RenewalItaly supports the heart-lung machine market through modernization of cardiovascular surgical infrastructure across major healthcare centers. Hospitals in Italy increasingly prioritize reliable perfusion systems that improve operational efficiency and support consistent surgical performance.
Segment Leadership and Growth Trends
Heart-lung Machine Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Cardiac Surgeries (Largest Segment) vs Acute Respiratory Failure Treatment (Fastest-Growing Segment)
The cardiac surgeries segment dominated the heart-lung machine market with a 42.82% share in 2026. The widespread use of heart-lung machines during open-heart procedures, including coronary artery bypass grafting and valve replacement surgeries, has established this segment as the primary application area. Growing emphasis on improving surgical precision, maintaining uninterrupted circulation during complex procedures, and enhancing patient safety continues to reinforce demand for these systems in cardiac operating rooms. The increasing adoption of advanced cardiopulmonary bypass technologies and the expansion of specialized cardiac care facilities further support the segment’s leading position.
The acute respiratory failure treatment segment is expected to witness the fastest growth as healthcare providers increasingly adopt extracorporeal life support technologies for critically ill patients requiring temporary cardiopulmonary assistance. Rising awareness of advanced life-support interventions, greater availability of intensive care infrastructure, and continuous improvements in perfusion technologies are encouraging broader clinical use beyond conventional cardiac surgery. Expanding capabilities in managing severe respiratory complications are also strengthening the adoption of heart-lung machines for this application.
End Use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Holding the largest share of the heart-lung machine market, the hospitals and clinics segment maintained its dominant position in 2026. Hospitals and specialized clinics possess the infrastructure, multidisciplinary surgical teams, and intensive care capabilities required for complex cardiothoracic procedures that depend on heart-lung machines. Their ability to manage high patient volumes, provide comprehensive perioperative care, and invest in advanced surgical equipment continues to sustain the segment’s leadership within the market.
Ambulatory surgical centers are emerging as the fastest-growing end-use segment as healthcare systems increasingly emphasize efficient surgical workflows and cost-effective treatment delivery. Advancements in minimally invasive surgical techniques, improved patient management protocols, and expanding capabilities of outpatient facilities are enabling selected cardiovascular procedures to be performed outside traditional hospital settings. Continued investments in specialized surgical infrastructure and streamlined care pathways are expected to accelerate adoption within this segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, Others | Cardiac Surgeries | Acute Respiratory Failure Treatment |
| End Use | Hospitals and Clinics, Ambulatory Surgical Centers, Others | Hospitals and Clinics | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Top players in the heart-lung machine market:
- Getinge AB (Sweden)
- LivaNova PLC (United Kingdom)
- Medtronic plc (Ireland)
- Terumo Corporation (Japan)
- Fresenius SE & Co. KGaA (Germany)
- Koninklijke Philips N.V. (Netherlands)
- Edwards Lifesciences Corporation (United States)
- Nipro Corporation (Japan)
- Braile Biomedica (Brazil)
- Eurosets S.r.l. (Italy)
Clinical expectations are driving manufacturers to compete through improvements in perfusion accuracy, patient safety, and ease of use rather than relying solely on core hardware performance. Development efforts increasingly focus on integrating monitoring technologies, intuitive control interfaces, and workflow enhancements that assist surgical teams during complex cardiovascular procedures. At the same time, suppliers capable of delivering comprehensive service support, equipment reliability, and compatibility with broader operating room environments are reinforcing their competitive position as healthcare providers prioritize long-term clinical performance and operational continuity.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Getinge AB (Sweden) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Medtronic plc (Ireland) | |||||||
| Terumo Corporation (Japan) | |||||||
| Fresenius SE & Co. KGaA (Germany) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Edwards Lifesciences Corporation (United States) | |||||||
| Nipro Corporation (Japan) | |||||||
| Braile Biomedica (Brazil) | |||||||
| Eurosets S.r.l. (Italy) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Mediyant Technologies | Jul-26 | Mediyant Technologies secured USFDA 510(k) clearance alongside a CDSCO Class C manufacturing licence for its New Century heart-lung machine. This establishes the first domestically manufactured system in India to hold both regulatory approvals, facilitating local production, reducing reliance on medical imports, and opening future export channels. |
| ASELSAN | May-25 | ASELSAN entered into a development partnership to create Turkey's first fully domestically produced heart-lung machine. This strategic collaboration introduces a material product innovation designed to establish native manufacturing capabilities for critical cardiac surgery equipment and reduce exposure to foreign medical supply chains. |
| Getinge | Feb-25 | Getinge announced the cessation of its cardiopulmonary surgical perfusion systems production to execute a strategic portfolio realignment. By exiting this segment, the company will redirect its operational focus and resources toward expanding its specialized organ transplant and extracorporeal membrane oxygenation (ECMO) business units. |
| LivaNova | Mar-23 | LivaNova secured U.S. FDA 510(k) clearance for its Essenz heart-lung machine designed for cardiopulmonary bypass procedures. The system integrates advanced cable management and refined component design to optimize the user interface and drive superior clinical outcomes, expanding the company's technical commercialization footprint. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Heart-lung Machine Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Machine Type | Conventional Heart-Lung Machines, Portable Heart-Lung Machines, Modular Heart-Lung Systems |
| Patient Age Group | Neonatal, Pediatric, Adult |
| Procedure Volume | Low-Volume Centers, Medium-Volume Centers, High-Volume Centers |
Heart-lung Machine Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Hospital Adoption & Procurement Pathways |
|
| Cardiopulmonary Bypass Workflow Integration |
|
| Heart-lung Machine Service & Support Models |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the heart-lung machine market?
What are the growth projections for the heart-lung machine industry?
How are advancements in extracorporeal circulation systems influencing the heart-lung machine market?
Why is the growing volume of cardiac bypass and transplant procedures driving heart-lung machine adoption?
Why do cardiac surgeries dominate the heart-lung machine market?
Why are ambulatory surgical centers the fastest-growing end-use segment?
Why does North America lead the heart-lung machine market?
What is driving heart-lung machine growth in Asia Pacific?
Which companies are driving growth in the heart-lung machine landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization